ATE157874T1 - Mittel zur verbesserung der peripheren durchblutung - Google Patents

Mittel zur verbesserung der peripheren durchblutung

Info

Publication number
ATE157874T1
ATE157874T1 AT93308301T AT93308301T ATE157874T1 AT E157874 T1 ATE157874 T1 AT E157874T1 AT 93308301 T AT93308301 T AT 93308301T AT 93308301 T AT93308301 T AT 93308301T AT E157874 T1 ATE157874 T1 AT E157874T1
Authority
AT
Austria
Prior art keywords
alkyl group
lower alkyl
hydrogen atom
group
agents
Prior art date
Application number
AT93308301T
Other languages
English (en)
Inventor
Sakae Murata
Hiroshi Narita
Minako Kaburaki
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE157874T1 publication Critical patent/ATE157874T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • External Artificial Organs (AREA)
  • Processing Of Meat And Fish (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vehicle Body Suspensions (AREA)
  • Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
  • Confectionery (AREA)
AT93308301T 1992-10-23 1993-10-19 Mittel zur verbesserung der peripheren durchblutung ATE157874T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28483492 1992-10-23

Publications (1)

Publication Number Publication Date
ATE157874T1 true ATE157874T1 (de) 1997-09-15

Family

ID=17683621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93308301T ATE157874T1 (de) 1992-10-23 1993-10-19 Mittel zur verbesserung der peripheren durchblutung

Country Status (10)

Country Link
EP (1) EP0595526B1 (de)
KR (1) KR100194825B1 (de)
AT (1) ATE157874T1 (de)
CA (1) CA2108871A1 (de)
DE (1) DE69313775T2 (de)
DK (1) DK0595526T3 (de)
ES (1) ES2108832T3 (de)
GR (1) GR3024700T3 (de)
SG (1) SG48753A1 (de)
TW (1) TW273511B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101640897B1 (ko) 2015-09-16 2016-07-29 주식회사 지에이치비 주낙통 접합기 및 주낙통 접합방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
JPH01186875A (ja) * 1988-01-19 1989-07-26 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の製法
CA2049655C (en) * 1990-09-17 1996-11-12 Akio Odawara Pharmaceutical composition for inhibiting platelet aggregation
CA2087743C (en) * 1992-02-06 1999-04-27 Akio Odawara Pharmaceutical composition for inhibiting platelet aggregation

Also Published As

Publication number Publication date
DK0595526T3 (da) 1997-10-13
CA2108871A1 (en) 1994-04-24
ES2108832T3 (es) 1998-01-01
KR940008684A (ko) 1994-05-16
SG48753A1 (en) 1998-05-18
DE69313775T2 (de) 1998-01-22
TW273511B (de) 1996-04-01
DE69313775D1 (de) 1997-10-16
EP0595526A1 (de) 1994-05-04
EP0595526B1 (de) 1997-09-10
GR3024700T3 (en) 1997-12-31
KR100194825B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
DE69716226D1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
ES2106573T3 (es) Composicion oftalmica que contiene un derivado de 1,5-benzoxatiepina para tratar glaucoma.
HU910681D0 (en) Medical solution
NO982873L (no) 1-metylkarbapenemderivater
NO168421C (no) Analogifremgangsmaate ved fremstilling av antiarytmiske midler
EP1034783A4 (de) Amidederivaten
DE3862791D1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE157874T1 (de) Mittel zur verbesserung der peripheren durchblutung
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
DE69102379D1 (de) Pharmazeutische Zusammensetzung zur Verhinderung der Plättchenaggregation.
AU1645897A (en) Benzopyran derivative and use of said benzopyran derivative for treating heart disease
ES2072644T3 (es) Composicion anticataratas.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE132748T1 (de) Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres
KR890009886A (ko) 심기능 부전의 예방 및 치료제

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee